Interim data shows Stelara promise in Crohn’s

14th February 2020 Uncategorised 0

Interim data from the Phase IIIb STARDUST study showed that 79% of patients with moderately to severely active Crohn’s disease (CD) achieved clinical response and 67% were in clinical remission.

More: Interim data shows Stelara promise in Crohn’s
Source: News